Holen Sie sich die Stockscreener-App
11.39
2.22%
-0.2994
Q 32 Bio Inc Aktie (QTTB) Neueste Nachrichten
QTTB: Q32 Bio Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Down 23.1% in 4 Weeks, Here's Why Q32 Bio (QTTB) Looks Ripe for a Turnaround - Yahoo Finance
Q32 Bio Inc. (QTTB) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits
Q32 Bio to present at three major healthcare investor conferences in September 2026 - Pluang
Q32 Bio to Participate in Upcoming September Investor Conferences - TradingView
Q32 Bio (FIXX) CSO logs automatic sale of 2,798 shares - Stock Titan
Q32 Bio CFO Lee Kalowski Executes Automatic RSU Tax Withholding Share Sale - Kalkine Media
Q32 Bio CEO Jodie Morrison sells $163,033 in company stock - Investing.com
Q32 Bio CEO Jodie Morrison sells $163,033 in company stock By Investing.com - Investing.com UK
Q32 Bio (FIXX) CEO’s automatic tax sale leaves 343,259 shares - Stock Titan
Q32 Bio: A Deep Dive (NASDAQ:QTTB) - Seeking Alpha
Q32 Bio CEO Jodie Pope Morrison Sells Shares to Cover RSU Tax Withholding - Kalkine Media
Wall Street Analysts Believe Q32 Bio (QTTB) Could Rally 163.42%: Here's is How to Trade - qz.com
Morgan Stanley initiates Q32 Bio stock at Overweight on drug potential - Investing.com
Q32 Bio Sees Unusually Large Options Volume (NASDAQ:QTTB) - MarketBeat
Q32 (QTTB) Earnings Snapshot: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Price Move - vinanet.vn
Q32 Bio Company Profile & Introduction - Moomoo
Wall Street Analysts See an 182.18% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High? - Yahoo Finance
Q32 Bio Inc. (QTTB) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Q32 Bio (NASDAQ:QTTB) stock in focus after mid-stage trial data - Kalkine Media
Point72 discloses 4.95% Q32 Bio Inc. (QTTB) holding in Schedule 13G/A - Stock Titan
Q32 Bio Inc. (QTTB) major holders cut reported stake to 0% - Stock Titan
Renaissance Technologies LLC Acquires 107,315 Shares of Q32 Bio Inc. $QTTB - MarketBeat
Q32 Bio (QTTB) Advances 2.34% as Shares Hold Above Key SupportMean Reversion Trade - vinanet.vn
Q32 Bio (QTTB) Holds Near $15.37 as Shares Consolidate Between Key Support and ResistanceGamma Squeeze - vinanet.vn
Q32 Bio Inc (NASDAQ: QTTB) Stock Price, News & Analysis - Kalkine
Q32 Bio Inc (QTTB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HC Wainwright Forecasts Q32 Bio's Q3 Earnings (NASDAQ:QTTB) - MarketBeat
Q32 Bio Inc. (NASDAQ:QTTB) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Q32 Bio Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Q32 Bio tops estimates as alopecia drug advances toward late-stage trials (QTTB:NASDAQ) - Seeking Alpha
Q32 Bio Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Q32 Bio Inc. posts second quarter 2026 results and updates corporate outlook - Traders Union
Q32 Bio reports Q2 2026 net loss $8.9M, cash $106.3M and $200M July offering - TradingView
Q32 Bio Inc. 2Q 2026: Net loss $(8.95)M, EPS $(0.44) — 10-Q Summary - TradingView
Q32 Bio (Nasdaq: QTTB) adds $187.6M follow-on cash for AA drug - Stock Titan
Q32 Bio (Nasdaq: QTTB) reports AA trial gains and $200M raise - Stock Titan
Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Q32 Bio Announces Q2 2026 Financial Results Highlighting Clinical-Stage Progress and Capital Needs - Kalkine Media
Q32 Bio Inc. Revenue Breakdown – NASDAQ:QTTB - TradingView
Q32 Bio Inc expected to post a loss of 54 cents a shareEarnings Preview - TradingView
Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 185.99%: Read This Before Placing a Bet - Yahoo Finance
Q32 Bio Inc. SEC Filing (Jul 29, 2026) - Stock Titan
H.C. Wainwright raises Q32 Bio stock price target to $36 on alopecia drug outlook - Investing.com
Q32 Bio Inc. Files Registration for 6.875 Million Shares Resale by Private Placement Investors - Kalkine Media
Q32 Bio Inc (QTTB) Balance Sheet - TradingKey
Q32 Bio Inc (QTTB) Income Statement - TradingKey
Q32 Bio Inc (QTTB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Q32 Bio Inc (QTTB) Cash Flow - TradingKey
QTTB|Q32 Bio Inc|Price:15.060|Chg%:-0.150 - TradingKey
QTTB|Q32 Bio Inc|Price:15.140|Chg%:-0.010 - TradingKey
Q32 Bio Inc (QTTB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Q32 Bio Inc (QTTB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Q32 Bio Inc (QTTB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Q32 Bio Inc (QTTB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Q32 Bio Inc (QTTB) Institutional Confidence - TradingKey
Q32 Bio Inc. (NASDAQ:QTTB) Sees Large Increase in Short Interest - MarketBeat
QTTB|Q32 Bio Inc|Price:15.290|Chg%:-0.660 - TradingKey
Q32 Bio Inc. (QTTB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Q32 Bio Inc Revenue Breakdown – DUS:DB0 - TradingView
Q32 Bio (QTTB) awards 10,826 stock options to director - Stock Titan
Q32 Bio (QTTB) corrects director’s 10,826 stock option award in Form 4/A - Stock Titan
Stock option grant for Q32 Bio Inc. (QTTB) director corrects prior award - Stock Titan
Form 4 Q32 Bio Inc For: 21 July By Investing.com - Investing.com Canada
Form 13D/A Q32 Bio Inc. For: 21 July By Investing.com - Investing.com Canada
Q32 Bio Inc. (QTTB) Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Management in Pre-Revenue PhaseCore Business Growth - vinanet.vn
OrbiMed reports 13.9% Q32 Bio ownership and 45-day lock-up (QTTB) - Stock Titan
Are You Looking for a Top Momentum Pick? Why Q32 Bio (QTTB) is a Great Choice - Yahoo Finance
0.71%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):